Nobiletin Attenuates Doxorubicin-Induced Cardiotoxicity by Promoting Pyruvate Kinase M2 Tetramerization.
BACKGROUND Doxorubicin (DOX) is an effective chemotherapeutic agent whose clinical use is limited by dose-dependent cardiotoxicity. Although nobiletin (NOB) exhibits cardioprotective effects in cardiovascular diseases, its role and underlying mechanisms in doxorubicin-induced cardiotoxicity (DIC) remain unclear. METH...